Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy
===========================================================================================================================================================

* Yeonggyeong Park
* Min Jeong Kim
* Yoonhee Choi
* Na Hyun Kim
* Leeseul Kim
* Seung Pyo Daniel Hong
* Hyung-Gyo Cho
* Emma Yu
* Young Kwang Chae